Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Oncogene ; 21(16): 2447-54, 2002 Apr 11.
Artigo em Inglês | MEDLINE | ID: mdl-11971179

RESUMO

Werner syndrome (WS) is a rare autosomal recessive genetic disorder causing premature aging. The gene (WRN) responsible for WS encodes a protein homologous to the RecQ-type helicase. WRN has a nucleolar localization signal and shows intranuclear trafficking between the nucleolus and the nucleoplasm. WRN is recruited into the nucleolus when rRNA transcription is reactivated in quiescent cells. Inhibition of mRNA transcription with alpha-amanitin has no effect on nucleolar localization of WRN whereas inhibition of rRNA transcription with actinomycin D releases WRN from nucleoli, suggesting that nucleolar WRN is closely related to rRNA transcription by RNA polymerase I (RPI). A possible function of WRN on rRNA transcription through interaction with RPI is supported by the results described here showing that WRN is co-immunoprecipitated with an RPI subunit, RPA40. Here we show that WS fibroblasts are characterized by a decreased level of rRNA transcription compared with wild-type cells, and that the decreased level of rRNA transcription in WS fibroblasts recovers when wild-type WRN is exogenously expressed. By contrast, exogenously expressed mutant-type WRN lacking an ability to migrate into the nucleolus fails to stimulate rRNA transcription. These results suggest that WRN promotes rRNA transcription as a component of an RPI-associated complex in the nucleolus.


Assuntos
DNA Helicases/fisiologia , RNA Polimerase I/metabolismo , RNA Ribossômico/biossíntese , Síndrome de Werner/enzimologia , Síndrome de Werner/genética , Amanitinas/farmacologia , Linhagem Celular , Nucléolo Celular/enzimologia , Nucléolo Celular/metabolismo , Células Cultivadas , DNA Helicases/análise , Replicação do DNA , Dactinomicina/farmacologia , Exodesoxirribonucleases , Fibroblastos/efeitos dos fármacos , Fibroblastos/enzimologia , Fibroblastos/metabolismo , Humanos , Cinética , Substâncias Macromoleculares , Inibidores da Síntese de Ácido Nucleico/farmacologia , RecQ Helicases , Transcrição Gênica , Síndrome de Werner/metabolismo , Helicase da Síndrome de Werner
2.
Oncogene ; 21(6): 954-63, 2002 Jan 31.
Artigo em Inglês | MEDLINE | ID: mdl-11840341

RESUMO

Werner syndrome (WS) is a recessive disorder characterized by premature senescence. Bloom syndrome (BS) is a recessive disorder characterized by short stature and immunodeficiency. A common characteristic of both syndromes is genomic instability leading to tumorigenesis. WRN and BLM genes causing WS and BS, encode proteins that are closely related to the RecQ helicase. We produced WRN-/-, BLM-/- and WRN(-/-)/BLM(-/-) mutants in the chicken B-cell line DT40. WRN-/- cells showed hypersensitivities to genotoxic agents, such as 4-nitroquinoline 1-oxide, camptothecin and methyl methanesulfonate. They also showed a threefold increase in targeted integration rate of exogenous DNAs, but not in sister chromatid exchange (SCE) frequency. BLM-/- cells showed hypersensitivities to the genotoxic agents as well as ultraviolet (UV) light, in addition to a 10-fold increase in targeted integration rate and an 11-fold increase in SCE frequency. In WRN(-/-)/BLM(-/-) cells, synergistically increased hypersensitivities to the genotoxic agents were observed whereas both SCE frequencies and targeted integration rates were partially diminished compared to the single mutants. Chromosomal aberrations were also synergistically increased in WRN(-/-)/BLM(-/-) cells when irradiated with UV light in late S to G(2) phases. These results suggest that both WRN and BLM may be involved in DNA repair in a complementary fashion.


Assuntos
Adenosina Trifosfatases/fisiologia , DNA Helicases/fisiologia , Reparo do DNA/fisiologia , 4-Nitroquinolina-1-Óxido/farmacologia , Adenosina Trifosfatases/deficiência , Adenosina Trifosfatases/genética , Sequência de Aminoácidos , Animais , Linfócitos B/efeitos dos fármacos , Linfócitos B/efeitos da radiação , Linfócitos B/ultraestrutura , Síndrome de Bloom/enzimologia , Síndrome de Bloom/genética , Camptotecina/farmacologia , Ciclo Celular , Linhagem Celular , Galinhas , Aberrações Cromossômicas , Células Clonais/efeitos dos fármacos , Células Clonais/metabolismo , Técnicas de Cocultura , DNA/efeitos dos fármacos , DNA/efeitos da radiação , Dano ao DNA , DNA Helicases/deficiência , DNA Helicases/genética , Resistência a Medicamentos , Etoposídeo/farmacologia , Marcação de Genes , Humanos , Metanossulfonato de Metila/farmacologia , Dados de Sequência Molecular , Testes de Mutagenicidade , Tolerância a Radiação , RecQ Helicases , Alinhamento de Sequência , Homologia de Sequência de Aminoácidos , Troca de Cromátide Irmã/efeitos dos fármacos , Especificidade da Espécie , Raios Ultravioleta , Síndrome de Werner/enzimologia , Síndrome de Werner/genética
3.
DNA Cell Biol ; 22(11): 727-35, 2003 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-14659045

RESUMO

We studied tumorigenic and phenotypic characteristics of pre- and postimmortal human B-lymphoblastoid cell lines (LCLs) transformed by Epstein-Barr virus (EBV): preimmortal LCLs showed low telomerase activity and a normal diploid karyotype while postimmortal LCLs showed much higher telomerase activity and maintained a clonal aneuploidic state. Among five postimmortal LCLs tested, LCLs N0005 and N6803 formed colonies in agar medium and showed marked aneuploidy, and N6803 was transplantable into nude mice indicating that it had a complete malignant phenotype, but all preimmortal LCLs and the remaining three postimmortal LCLs lacked these characteristics. The products of tumor suppresser genes, p16(INK4A) and pRb, were downregulated in these two LCLs, and the p53 gene was mutated in N0005 LCL. We believe these results showed for the first time that some postimmortal EBV-transformed LCLs can become tumorigenic, contrary to previous reports, and that these LCLs provide an in vitro model of tumorigenesis induced by EBV.


Assuntos
Linfócitos B , Linhagem Celular Tumoral , Transformação Celular Neoplásica , Aneuploidia , Animais , Linfócitos B/enzimologia , Linfócitos B/patologia , Linfócitos B/virologia , Transformação Celular Viral , Diploide , Regulação para Baixo , Genes do Retinoblastoma , Genes Supressores de Tumor , Genes p16 , Genes p53 , Herpesvirus Humano 4 , Humanos , Técnicas In Vitro , Camundongos , Camundongos Nus , Mutação , Fenótipo , Telomerase/metabolismo
4.
Biol Pharm Bull ; 25(9): 1247-9, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12230131

RESUMO

We previously demonstrated the preventive effect of sesamin, a lignan from sesame oil, on the development of several experimental models of hypertension. In the present study, we explored the mechanisms underlying the antihypertensive effect of sesamin using the deoxycorticosterone acetate (DOCA)-salt rat hypertensive model. After a 5-week treatment period, aortic superoxide (O2-) production was measured in the lucigenin chemiluminescence assay. Chemiluminescence signals significantly decreased in sesamin-containing diet-fed DOCA-salt hypertensive rats compared with those in the normal diet-fed DOCA-salt rats, although the signals in sham-operated control animals were not affected by the sesamin feeding. In addition, there was a positive correlation between systolic blood pressure and aortic O2- production. These findings suggest that sesamin feeding inhibits enhanced vascular O2- production in DOCA-salt hypertensive rats and that the antioxidative action of sesamin may contribute to its antihypertensive activity.


Assuntos
Anti-Hipertensivos/farmacologia , Aorta Torácica/efeitos dos fármacos , Dioxóis/farmacologia , Lignanas/farmacologia , Superóxidos/antagonistas & inibidores , Animais , Anti-Hipertensivos/uso terapêutico , Aorta Torácica/metabolismo , Dioxóis/uso terapêutico , Hipertensão/induzido quimicamente , Hipertensão/tratamento farmacológico , Hipertensão/metabolismo , Lignanas/uso terapêutico , Masculino , Ratos , Ratos Sprague-Dawley , Superóxidos/metabolismo
5.
Biol Pharm Bull ; 26(12): 1701-5, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14646174

RESUMO

In the present study, we evaluated the relationship between the antihypertensive effect of sesamin, a lignan from sesame oil, and its antioxidative activity in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. After a 5-week treatment period, systolic blood pressure was significantly elevated in normal diet-fed DOCA-salt animals compared with cases in sham-operated animals. Sesamin feeding, tempol (a superoxide dismutase mimetic) treatment or antihypertensive drugs combination (triple therapy; reserpine, hydralazine, hydrochlorothiazide) significantly suppressed the development of DOCA-salt-induced hypertension. Compared with sham-operated rats, the normal diet-fed DOCA-salt rats revealed marked increases in aortic superoxide (O(2)(-)) production. These increases in O(2)(-) production were significantly suppressed by sesamin feeding or tempol treatment, but not by triple therapy. Acetylcholine (Ach)-induced endothelium-dependent relaxation was markedly decreased in normal diet-fed DOCA-salt rats, compared with cases in sham-operated rats. Sesamin feeding and triple therapy significantly improved the DOCA-salt-induced impairment of endothelium-dependent relaxation. However, tempol treatment had no effect on the impaired vasodilator responses induced by DOCA-salt treatment. In DOCA-salt rats with or without sesamin feeding, systolic blood pressure significantly correlated with both aortic O(2)(-) production and endothelium-dependent vascular relaxation. These findings suggest that sesamin feeding inhibits the enhancement of aortic O(2)(-) production in DOCA-salt hypertensive rats, and this effect may contribute to the antihypertensive effect of sesamin. Sesamin feeding-induced improvement of endothelial dysfunction seems to result from the above antioxidative and antihypertensive effects.


Assuntos
Aorta/efeitos dos fármacos , Dioxóis/uso terapêutico , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/patologia , Lignanas/uso terapêutico , Estresse Oxidativo/efeitos dos fármacos , Acetilcolina/farmacologia , Administração Oral , Animais , Anti-Hipertensivos/administração & dosagem , Anti-Hipertensivos/farmacocinética , Anti-Hipertensivos/uso terapêutico , Aorta/metabolismo , Pressão Sanguínea/efeitos dos fármacos , Óxidos N-Cíclicos/administração & dosagem , Desoxicorticosterona , Dioxóis/química , Dioxóis/farmacologia , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Quimioterapia Combinada , Endotélio Vascular/fisiologia , Hipertensão/induzido quimicamente , Hipertensão Renovascular/tratamento farmacológico , Hipertensão Renovascular/fisiopatologia , Hipertensão Renovascular/prevenção & controle , Lignanas/química , Lignanas/farmacologia , Masculino , Músculo Liso Vascular/efeitos dos fármacos , Músculo Liso Vascular/fisiologia , Ratos , Ratos Sprague-Dawley , Marcadores de Spin , Superóxidos/antagonistas & inibidores , Superóxidos/metabolismo , Vasodilatação/efeitos dos fármacos , Vasodilatação/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA